| 2025-02-20 | Class II | Nonconforming Material/Component | The RSV target may give a late Ct value and could potentially not pass QC. | 28 units | |
| 2025-02-20 | Class II | Process control | The A549 human cell target (human cells for sample adequacy control) may give a late Ct value. | 6 units | |
| 2025-01-20 | Class II | Under Investigation by firm | Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration of one target (HPV 16 | 27 units | |
| 2025-01-20 | Class II | Under Investigation by firm | Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration of one target (HPV 16 | 16 units | |
| 2024-01-08 | Class II | Process control | The negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the negative control. | 580 packages | |
| 2022-07-27 | Class III | Process control | Product not registered for use in the UK | 2 | 2024-08-02 |
| 2022-03-24 | Class II | Process control | QC process was not adequate for the specification range. | 1 ea | 2023-01-09 |
| 2022-03-22 | Class II | Process control | The QC process was not adequate for the specification range. | 2 ea | 2023-01-09 |
| 2022-03-03 | Class II | Incorrect or no expiration date | Shelf-life for the 8244 Pneumonia (33 Targets) Control Panel determined to be 6 months instead of 18 months. | 13 units | 2024-01-16 |
| 2022-02-25 | Class II | Nonconforming Material/Component | Distributed product did not undergo proper release testing. | 80 units | 2024-01-16 |
| 2021-08-20 | Class II | Material/Component Contamination | The product indicated is contaminated with a plasmid DNA that contains the target SARS-CoV-2 sequences. | 127 | 2023-01-12 |
| 2021-08-20 | Class II | Material/Component Contamination | The SARS-CoV-2 Process Control (Pellet) contains RNA transcripts that include diagnostically relevant SARS-CoV-2 targets (CDC and WHO consensus sequences). | 218 | 2023-01-12 |
| 2020-01-03 | Class II | Process control | Product 8208 Vaginal Verification Panel is a 6 pool kit and has contaminant Candida krusei in Pool 2 (subcomponent 6063). Candida krusei is an organism intended to be contained in Pool 6 of the kit. This should have no impact on patient te | 9 | 2020-09-16 |
| 2019-12-16 | Class II | Device Design | The recommended hydration fluid for the 8180 Gram-Positive Blood Culture Control Panel (Inactivated Pellet), has changed from sterile 0.85% saline or sterile blood culture media to sterile DI water or pH 7.2 phosphate buffer. | 810 | 2020-12-11 |
| 2017-06-06 | Class II | Process design | Real-time shelf life testing failed at 24 months | 1 | 2023-01-17 |
| 2017-06-06 | Class II | Process design | Real-time shelf life testing failed at 24 months | 29 units | 2023-01-17 |
| 2017-06-06 | Class II | Process design | Real-time shelf life testing failed at 24 months | 1 unit | 2023-01-17 |
| 2017-06-06 | Class II | Process design | Real-time shelf life testing failed at 24 months | 1 unit | 2023-01-17 |
| 2017-06-06 | Class II | Process design | Real-time shelf life testing failed at 24 months | 8 units | 2023-01-17 |